Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

Clinical trial NCT07120698 · RECRUITING

Trial details

NCT number: NCT07120698
Sponsor: Guangdong Association of Clinical Trials
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)MRD II-IIIB Stages Adjuvant Immunotherapy

Start date: 2025-11-05
Primary completion: 2029-06-26
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.